Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Retirees seeking reliable, recurring income can benefit from a small, focused trio of high-yielding dividend stocks. ...
Ethereum’s selloff tests whether the network’s neutrality-first model can shield value as leadership exits hit the Fo...
A federal judge granted preliminary approval to a group of tuccori opt-in settlements preliminary totaling $106 milli...
When a famous couple welcomes a second child, it shines a spotlight on budgeting, insurance, and future planning. Thi...
As rate pressure persists, INDS faces mixed signals from its industrial and self-storage holdings. This dividend safe...
Roswell is quietly drawing retirees thanks to affordable housing and sun-filled days. Investors should watch how this...
Bitcoin cools after oil-driven volatility fades, shifting focus to liquidity, rate bets, and ETF flows as Brent trade...
A Florida couple faced a devastating scam that drained their savings, cost them their home and car, and upended their...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
A looming 10-year treasury signal could temper SCHD's 2026 rally as rising yields threaten valuations for dividend-fo...
South Korea revealed a sweeping $590 billion plan to boost memory chips and AI hardware, triggering gains in semicond...